The largest U.S. banks are scrutinizing members of the Federal Reserve for any insight into how the central bank will tinker interest rates.Banksread more
Facebook's cryptocurrency project has already been met with skepticism from policymakers around the world.Technologyread more
The U.S. and China restarted their trade talks, but signs are showing a comprehensive deal could be a long way off, if it happens at all.Marketsread more
Stone, 66, a notorious Republican political operative who has described himself as a "dirty trickster," had previously been dressed down by the judge for his public remarks...Politicsread more
The Biden team's second-quarter Federal Election Commission filing shows that the campaign wrote a check of just over $5,300 on June 28 to Sheehan Associates for "strategic...2020 Electionsread more
See which stocks are posting big moves after the bell on July 16.Market Insiderread more
United Airlines' second-quarter profit tops estimates but questions about the 737 Max linger.Airlinesread more
Three civil rights groups filed a federal lawsuit on Tuesday challenging the Trump administration's new asylum rule, which bars asylum claims from most noncitizens who travel...Politicsread more
Google VP of policy Karan Bhatia started sweating early as hearing chair Ted Cruz brings out an internal presentation created within the company.Technologyread more
At a hearing with the House Judiciary subcommittee on antitrust, an Amazon representative disputed a key argument about how it users sellers' data.Technologyread more
Charles Evans spoke Tuesday at CNBC's @Work Human Capital + Finance Conference in Chicago. The Fed president said he is worried about low inflation and several other issues.At Workread more
"Here is my new rule: try not to buy a stock that is in the middle of a short squeeze, because even if you really like the underlying company, you will almost always be able to get a better price as long as you are patient," the "Mad Money " host said.
Shares of Herbalife spiked at the open on Thursday following a better-than-expected earnings report. However, with 31 percent of the stock affected by short sellers, Cramer expected fireworks anyways. Management raised its full year earnings per share guidance for 2016 to a range of $4.50 to $4.80, which was an increase from the initial expectation of $4.40 to $4.75.
But the real reason why short sellers will be covering their positions has nothing to do with guidance.
Cramer suspects that it will be because Herbalife didn't fall apart, despite the company's settlement with the Federal Trade Commission last month that required it to change many of its practices. Noted activist and short-seller Bill Ackman, head of Pershing Square Capital, recently insinuated that the action taken by the FTC had a larger impact than even Herbalife realizes, when he stated on an investor call that "Herbalife actually has been shut down by the FTC, they just haven't realized it."
Based on this commentary, Cramer believes that Ackman will now double down on his negativity, rather than declaring victory that he helped to clean up some of the practices for Herbalife.
"He will do so, I believe, to prove that the FTC-mandated changes are bad for business. That is why if you are going to play the short game you have to come back to the fundamentals," Cramer said.
With fundamentals in mind, Cramer struggled to determine what the normalized earnings power should be for Herbalife. Earnings power of $4.80 is impressive, but the company isn't as strong as even Bristol-Myers Squibb, he said.
In the end, Herbalife is a supplements business. GNC currently trades at a 7 times multiple. Assuming Herbalife deserves double the price-to-earnings multiple of GNC because of its faster growth rate, Cramer calculated it is $67 a share. Herbalife closed at $67 on Thursday.
"You are dealing with a stock that seems fairly valued, which means the only reason to own it here is because you're expecting a short squeeze," Cramer said.
Investors that make that bet either believe Ackman will cover, or Herbalife will go private again. Both are unlikely for Cramer. That means Herbalife is nothing but a supplements company that trades off points, and that's not enough to take the stock dramatically higher.
"I can't endorse this one until Herbalife can demonstrate sustained earnings power with the changes to the business model, and for that all we can do is wait and see," Cramer said.
Square shot up 8 percent on Thursday after it also reported better-than-expected earnings. In addition to payment processing, Square also makes loans to small and medium sized customers. And while Cramer has always said it is hard to value a company plagued with credit risk, some of those fears were alleviated with the latest earnings report.
"I heard a lot of people say this stock surged because the company reported better than expected revenues, but I think that's a mistake. I believe Square's going higher because they explained their credit exposure to merchants in a way that made us feel like we no longer need to be concerned that Square is some kind of wayward bank masquerading as a tech company," Cramer said.
That translated Square into a high-growth loss-making company in the very competitive payments space. Cramer estimated that the stock was worth more than it was on Wednesday, but not more than the huge gain it had on Thursday because of the tough payment environment.
Cramer's ultimate target for Square was its all-time high price of $15. However, risk has grown for small-to-medium sized retailers since it hit that price in March.